Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Kereiakes Dean J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 239-246

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Volpe Massimo  

Clinical Drug Investigation, Vol. 29, Iss. 1, 2009-01 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 427-439

Adis International

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite